Hospital Medicine

The protocol appeared safe, with no associated increases in the incidence of hypoglycemic events during hospitalization or 30-day mortality.

A survey analysis suggests the worst of turnover in the workforce occurred in 2020, but focus is needed to recover health care workers from specific fields.

National registry data suggest management and outcomes of ST-elevation myocardial infarction are returning to pre-pandemic levels, though vaccinated patients have fared better in mortality.

Data from PROMPT-HF show clinicians are more likely to add 1 of 4 topline drug classes to a patient's HFrEF regimen when alerted on the opportunity.

Mikhail Kosiborod, MD, discusses EMPULSE findings supporting hospital-stage treatment with the SGLT-2—regardless of patients' diabetes status.

Dr. Rafael Pérez-Figueroa talks about how the pandemic has exacerbated racial inequities on multiple levels saying that people of color have been overrepresented in jobs with high exposure to COVID-19, leading to disproportionate infections and death.

Deepak L. Bhatt, MD, MPH, reviews the latest phase 2b trial data supporting the fast-acting monoclonal antibody infusion for bleeding risk reversal.

VOYAGER PAD subgroup analyses showed the anticoagulant reduced likelihood of hospitalization without increasing bleeding risk in patients with CKD.

Investigators believe the novel monoclonal antibody may be a suitable agent in patients with major bleeding risk or those undergoing surgery.

The NaV1.8 inhibitor VX-548 shows promising potential as a non-opioid acute pain treatment.

Team-based care shows the reduction of multiple risk factors, attainment of multiple treatment targets, and empowerment among high-risk patients with DKD.

RBX2660 is a live microbiome therapeutics that could build on the success of fecal microbiota transplantation for treating patients with recurrent C difficile infections.

Data from Australia show a T-cell antigen-inducing vaccine was unable to provide greater prevention of flu incidence than a placebo.

Large variations were observed in the transition between monotherapy and dual combination therapy for hypertension across countries and demographic group.

Strategies to improve enrollment of underrepresented populations were centered on study design and site selection, community engagement, and changing the research paradigm.

Greater increases were observed among members of racial and ethnic minority groups, with the highest increase among non-Hispanic Black individuals.

Case-control analyses suggest older patients may cognitively age by about 8 years within 6 months of being discharged for severe COVID-19.

Cross-sectional analysis of national survey data suggest students with multiple marginalized identities are more prone to treatment that could lead to burnout.

Experts observed a significant increase in monthly overdose deaths during Spring 2020, before a gradual decrease to 2019 rates.

Phase 3 data show the C3 inhibitors' sustained benefit for the common form of vision loss. A primary author explains the significance of the new findings.

New data show the highest quintile of census-reported parental income is far more represented among future physicians than lower income levels, regardless of race.

ChristianaCare’s Gene Editing Institute experts join the podcast to discuss the latest developments in gene editing.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

Findings suggest mortality risk from the respiratory virus is twice greater among adults with CHF.